// App-Quantinova.ai

706 : Prognostication, Survival and Treatment-Related Outcomes in HIV-Associated Burkitt Lymphoma (HIV-BL): A US and UK Collaborative Analysis

Researchers

Presenter

  • Juan Pablo Alderuccio

Principal Investigators

  • Andrew M. Evens

  • Graham P. Collins

  • Alexey Danilov

  • Mark Bower

  • Deepa Jagadeesh

  • Catherine Zhu

  • Amy Sperling

  • Seo-Hyun Kim

  • Ryan Vaca

  • Catherine Wei

  • Suchitra Sundaram

  • Nishitha Reddy

  • Alessia Dalla Pria

  • Christopher D'Angelo

  • Umar Farooq

  • David A. Bond

  • Stephanie Berg

  • Michael C. Churnetski

  • Amandeep Godara

  • Nadia Khan

  • Yun Kyong Choi

  • Shireen Kassam

  • Maryam Sarraf Yazdy

  • Emma Rabinovich

  • Frank Post

  • Gaurav Varma

  • Reem Karmali

  • Madelyn Burkart

  • Peter Martin

  • Albert Ren

  • Ayushi Chauhan

  • Catherine Diefenbach

  • Allandria Straker-Edwards

  • Andreas Klein

  • Kristie A. Blum

  • Kirsten M Boughan

  • Agrima Mian

  • Bradley Haverkos

  • Victor M. Orellana-Noia

  • Vaishalee P. Kenkre

  • Adam Zayac

  • Seth M Maliske

  • Narendranath Epperla

  • Paolo F Caimi

  • Scott E. Smith

  • Manali Kamdar

  • Parameswaran Venugopal

  • Tatyana A. Feldman

  • Daniel Rector

  • Stephen D. Smith

  • Andrzej Stadnik

  • Craig A. Portell

  • Yong Lin

  • Seema Naik

  • Silvia Montoto

  • Izidore S. Lossos

  • Kate Cwynarski

Medical Centers

  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL

  • Brown University Urology, Providence, RI

  • Rutgers Cancer Institute of New Jersey, Piscataway, NJ

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Toni Stephenson Lymphoma Center, City of Hope Comprehensive Cancer Center, Duarte, CA

  • National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, United Kingdom

  • Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA

  • Rush University Medical Center, Chicago, IL

  • Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • Vanderbilt University Medical Center, Nashville, TN

  • Chelsea and Westminster Hospital, London, United Kingdom

  • Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI

  • Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Department of Cancer Biology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL

  • Winship Cancer Institute, Emory University Medical Center, Atlanta, GA

  • Tufts Medical Center, Boston, MA

  • Fox Chase Cancer Center, Philadelphia, PA

  • New York University School of Medicine Cancer Institite, New York, NY

  • Kings College London, London, United Kingdom

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • University of Illinois at Chicago, Cleveland Heights, OH

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Division of Hematology/Oncology, Northwestern University, Chicago, IL

  • Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • University of Illinios at Chicago, Chicago, IL

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

  • Division of Hematology/Oncology Tufts Medical Center, Boston, MA

  • Emory University, Atlanta, GA

  • Adult Hematologic Malignancies & Stem Cell Transplant Program, University Hospitals, Seidman Cancer Center, Cleveland, OH

  • Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH

  • University of Colorado Cancer Center, Aurora, CO

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • University Hospital of Cleveland, Cleveland, OH

  • Loyola University Medical Center, Maywood, IL

  • Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO

  • Pediatric Hematology & Oncology, Rush University Medical Center, Chicago, IL

  • Hackensack University Medical Center, Oradell, NJ

  • John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, NJ

  • University of Washington, Seattle, WA

  • Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR

  • Division of Neuro-Oncology, University Of Virginia, Charlottesville, VA

  • Cancer Institute, Penn State Hershey Medical Center, Hershey, PA

  • Division of Haemato-Oncology, St Bartholomews Hospital, Barts Health NHS Trust, London, United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Burkitt lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved